Glaxosmithkline Pharmaceuticals reports 35% rise in Q1 consolidated net profit

22 Jul 2019

Glaxosmithkline Pharmaceuticals has reported results for first quarter ended June 30, 2019.

The company has reported 28.07% rise in its net profit at Rs 113.46 crore for the quarter under review as compared to Rs 88.59 crore for the same quarter in the previous year. Total income of the company increased by 8.64% at Rs 818.56 crore for Q1FY20 as compared Rs 753.43 crore for the corresponding quarter previous year.

On the consolidated basis, the company has reported a rise of 35.04% in its net profit at Rs 113.54 crore for the quarter under review as compared to Rs 84.08 crore for the same quarter in the previous year. Total income of the company increased by 8.64% at Rs 818.78 crore for Q1FY20 as compared Rs 753.66 crore for the corresponding quarter previous year.

Related Glaxosmithkline Pharmaceuticals Ltd. Links:

Glaxosmithkline Phar Share Price

1573.90 1.25 (0.08%) Sep 30, 18:01
1 Year Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 500.50
Dr. Reddys Lab 5187.05
Lupin 1007.10
Piramal Enterprises 1251.95
Cadila Healthcare 394.90
View more..
Sensex vs Glaxosmithkline Phar
Puchho Befikar
SEBI Registered: Investment Adviser - INA000013323
Research Analyst - INH000000719

Callback